These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 1609034

  • 1. Plasma prolactin and homovanillic acid as markers for psychopathology and abnormal movements after neuroleptic dose decrease.
    Newcomer JW, Riney SJ, Vinogradov S, Csernansky JG.
    Psychopharmacol Bull; 1992; 28(1):101-7. PubMed ID: 1609034
    [Abstract] [Full Text] [Related]

  • 2. Plasma prolactin and homovanillic acid as markers for psychopathology and abnormal movements during maintenance haloperidol treatment in male patients with schizophrenia.
    Newcomer JW, Riney SJ, Vinogradov S, Csernansky JG.
    Psychiatry Res; 1992 Mar; 41(3):191-202. PubMed ID: 1594706
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Plasma homovanillic acid differences in clinical subgroups of first episode schizophrenic patients.
    Baeza I, Castro-Fornieles J, Deulofeu R, de la Serna E, Goti J, Salvà J, Bernardo M.
    Psychiatry Res; 2009 Jul 30; 168(2):110-8. PubMed ID: 19501918
    [Abstract] [Full Text] [Related]

  • 7. A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients.
    Chouinard G, Jones B, Remington G, Bloom D, Addington D, MacEwan GW, Labelle A, Beauclair L, Arnott W.
    J Clin Psychopharmacol; 1993 Feb 30; 13(1):25-40. PubMed ID: 7683702
    [Abstract] [Full Text] [Related]

  • 8. Relationship of symptomatology, gender, and antipsychotic drug treatment with plasma homovanillic acid in schizophrenia.
    Zhang ZJ, Reynolds GP, Ramchand C, Peet M, Shah S.
    Acta Pharmacol Sin; 2001 Jan 30; 22(1):76-80. PubMed ID: 11730567
    [Abstract] [Full Text] [Related]

  • 9. Plasma homovanillic acid levels in schizophrenic patients: correlation with negative symptoms.
    Dávila R, Zumárraga M, Basterreche N, Arrúe A, Anguiano JB.
    Psychiatry Res; 2007 May 30; 151(1-2):163-8. PubMed ID: 17434602
    [Abstract] [Full Text] [Related]

  • 10. Plasma prolactin and plasma homovanillic acid: predictors of clinical response in schizophrenia.
    Davila R, Gonzalez MA, Zumarraga M, Andia I, Guimon J, Silva RR, Friedhoff AJ.
    Biol Psychiatry; 1995 Aug 15; 38(4):267-9. PubMed ID: 8547450
    [No Abstract] [Full Text] [Related]

  • 11. Tardive dyskinesia and plasma homovanillic acid.
    Moore DC, Glazer WM, Bowers MB, Heninger GR.
    Biol Psychiatry; 1983 Dec 15; 18(12):1393-402. PubMed ID: 6140961
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Plasma HVA, tardive dyskinesia and psychotic symptoms in long-term drug-free inpatients with schizophrenia.
    Muscettola G, Barbato G, de Bartolomeis A, Monteleone P, Pickar D.
    Psychiatry Res; 1990 Sep 15; 33(3):259-67. PubMed ID: 2243901
    [Abstract] [Full Text] [Related]

  • 15. Molindone and haloperidol in tardive dyskinesia.
    Glazer WM, Hafez HM, Benarroche CL.
    J Clin Psychiatry; 1985 Aug 15; 46(8 Pt 2):4-7. PubMed ID: 2862139
    [Abstract] [Full Text] [Related]

  • 16. Prolactin response in tardive dyskinesia.
    Wolf ME, Bowie L, Keener S, Mosnaim AD.
    Biol Psychiatry; 1982 Apr 15; 17(4):485-90. PubMed ID: 7082714
    [No Abstract] [Full Text] [Related]

  • 17. Minimal effective dose and relapse--double-blind trial: haloperidol decanoate vs. placebo.
    Eklund K, Forsman A.
    Clin Neuropharmacol; 1991 Apr 15; 14 Suppl 2():S7-12; discussion S12-5. PubMed ID: 1684310
    [Abstract] [Full Text] [Related]

  • 18. Plasma catecholamine metabolites and early response to haloperidol.
    Bowers MB, Swigar ME, Jatlow PI, Goicoechea N.
    J Clin Psychiatry; 1984 Jun 15; 45(6):248-51. PubMed ID: 6725216
    [Abstract] [Full Text] [Related]

  • 19. Methylphenidate response, psychopathology and tardive dyskinesia as predictors of relapse in schizophrenia.
    Lieberman JA, Alvir J, Geisler S, Ramos-Lorenzi J, Woerner M, Novacenko H, Cooper T, Kane JM.
    Neuropsychopharmacology; 1994 Oct 15; 11(2):107-18. PubMed ID: 7840862
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.